CONFIRMED: Quercetin-tocotrienols combination combats cancer

Image: CONFIRMED: Quercetin-tocotrienols combination combats cancer

The battle against cancer is heading into new territory, as scientists explore the healing ability of substances that support the body’s cells, instead of killing them off. Researchers from the Italian National Institute of Health and Science on Aging (INRCA) have made a breakthrough discovery for preventing the spread of malignant tumors. A natural plant-based combination, including quercetin and tocotrienols, effectively targets aging cells that cause chronic inflammation and cancer. This dynamic, anti-cancer duo causes stubborn cancer cells to die off and simultaneously promotes the growth of normal cells.

This dynamic duo heals the body at the cellular level by triggering a die-off sequence within aging and malignant cells. If old, decrepit cells become inefficient at performing cellular division, new cells cannot be created. If these senile cells refuse to die off, a condition called cellular senescence sets in. This causes an accumulation of aged cells that emit pro-inflammatory chemicals into the body. This process promotes aging in the body and increases cancer risk. Quercetin and tocotrienols help to remove aging cells so healthy cells have space to flourish.

Moreover, quercetin and tocotrienols identify malignant cancer cells and speed up their cellular senescence. This dynamic duo effectively target unwanted cancer cells and speed up their death, preventing cancer cell replication. The two natural substances remove inflammatory, aging cells and stop malignant cells from growing. This combination is a highly intelligent form of medicine that deciphers dangerous cells and manipulates cellular senescence so that the body can heal itself. The combination can be employed as an adjunct therapy for cancers of many origins. This combination can be used to prevent cancer from taking hold and stop early cancers in their tracks.

The power of the elements: Discover Colloidal Silver Mouthwash with quality, natural ingredients like Sangre de Drago sap, black walnut hulls, menthol crystals and more. Zero artificial sweeteners, colors or alcohol. Learn more at the Health Ranger Store and help support this news site.

Anti-cancer intelligence of tocotrienols

Tocotrienols are an anti-inflammatory type of vitamin E that can be found in wheat germ, barley, oat, rye, cranberries, blueberries, kiwi, plum, coconut, and some nuts. It is also isolated in supplement form. Research confirms that this form of vitamin E can reverse cell cycle arrest and reduce DNA damage, especially for treatment of breast cancer, pancreatic cancer, and melanoma. However, assimilation of tocotrienols in the human intestine is poor because they are lipophilic in nature (they dissolve in lipids and fats). Researchers must find ways to increase the bio-availability of tocotrienols to increase this vitamin’s therapeutic effects. Intestinal absorption depends upon the secretion of bile and transporters such as ?-tocopherol transfer protein (?-TTP); therefore, assimilation of tocotrienols occurs more readily with food. Nutritionists recommend a daily dose of 150 mg of tocotrienols. One should expect to see therapeutic benefits with supplementation after ninety days.

The healing nature of quercetin

Quercetin is a plant-based flavonoid and antioxidant that helps plants defend against disease. When quercetin is combined with tocotrienols, synergy is created; together these natural substances slow the aging process, prolong the life of healthy cells, and induce apoptosis of malignant cancer cells. Because of its anti-inflammatory properties, quercetin can benefit seasonal allergies, asthma, bronchitis, and congestion. Quercetin is commonly found in apples, tea, onions, nuts, berries, cauliflower and cabbage and can be isolated and consumed in the form of a supplement. To rid the body of aging cells, nutritionists recommend a daily dose of quercetin (500 to 800 mg) for up to three consecutive months, followed by a maintenance dose of 150 mg a day. It is best to consult a healthcare professional, as many medications can adversely interact with the body when healing substances are introduced.

Sources include:


Should I Take Aspirin to Prevent Cancer?

A steady drumbeat of research suggests that taking a small dose of daily aspirin over a period of years can reduce the risk of certain cancers. The strongest data favoring aspirin as a preventive are for cancers of the colon and rectum, stomach, and esophagus.

aspirinIn April 2016, the U.S. Preventive Services Task Force released a recommendation stating that a low-dose aspirin regimen is most beneficial for adults age 50-59.

“Our research has demonstrated a benefit for aspirin in reducing the risk of colorectal cancer, and we are pleased with the new recommendations from the U.S. Preventive Services Task Force,” says Charles S. Fuchs, MD, MPH, director of the Gastrointestinal Cancer Center at Dana-Farber. “Our ongoing research seeks to fully understand the mechanisms by which aspirin reduces the risk of colorectal cancer and assess whether we can leverage those findings to improve the treatment of patients with established colorectal cancer.”

According to the Task Force recommendations, the adults most likely to benefit from aspirin are those who are not at risk for gastrointestinal bleeding, have a life expectancy of at least 10 years, and who are willing to take low-dose aspirin daily for at least 10 years.

For adults age 60-69, the Task Force recommends individuals speak with their primary care physician about the risks and benefits of aspirin use, and whether a low-dose regimen is right for them. The Task Force’s findings did not have sufficient evidence showing an aspirin regimen would be beneficial for adults younger than 50 or older than 70.

The biggest obstacle to recommending routine aspirin use is the significant risk of causing gastrointestinal bleeding, which can be fatal. So, it is important to weigh the risks and benefits with a physician.

Data supporting an aspirin regimen

In August 2014, researchers from London’s Queen Mary University concluded that daily aspirin taken over 10 years reduced the risk of developing cancers of the digestive tract – colon, stomach, and esophagus – by as much as 40 percent, and had a lesser impact on the number of lung, breast and prostate cancer diagnoses. The leader of the research – published in the Annals of Oncology,  said “the evidence is that everyone between 50 and 65 should consider [taking daily] aspirin.”

A team at Fox Chase Cancer Center in Philadelphia has also presented research showing that low-dose aspirin helps suppress inflammatory pathways that feed prostate cancer cell formation. And another study in 2014 reported that daily aspirin could reduce the risk of ovarian cancer by 20 to 34 percent.

However, it is important to consider that many of these aspirin studies are observational and designed to look for preventive effects in heart disease, rather than side-by-side comparisons of aspirin versus no aspirin for cancer prevention.

More research is needed

A 2010 review of four clinical trials revealed that over a 20-year period, taking low doses of aspirin was associated with a 24 percent reduction in colon cancer cases and a 35 percent drop in deaths.

However, a study by researchers at Dana-Farber and Massachusetts General Hospital has suggested that this benefit may be limited to individuals who are already at high risk of colon cancer because they have elevated levels of an inflammatory factor called TNFR-2in their blood.  Fuchs, senior author of the study, noted that TNFR-2 was the only one of three inflammatory markers that was relevant to colon cancer risk, showing that testing for specific biomarkers likely will be needed to identify patients who might benefit from preventive use of aspirin or other anti-inflammatory drugs.

This finding reflects a larger set of unanswered questions about aspirin as a cancer preventive: Who might benefit – people who are at low risk for developing cancer, or those at high risk? How long does it take for aspirin’s presumed protective effect to kick in, and how long must the drug be taken for maximum benefit?

Research continues. Meanwhile, patients should discuss the pros and cons of daily aspirin, as with any course of medication, with their doctor.

Watch the video discussion. URL: